+1 (855) PLE.XISION (753.9474) info@plexision.com

Blog

You are here

15
Nov

Predicting cytomegalovirus viremia….with CMV-specific T-cells

Predicting cytomegalovirus viremia after liver or intestine transplantation (LTx, ITx) with CMV-specific T-cell subsets
10
Sep

FDA approves PleximmuneTM for personalized prediction of transplant rejection in children

PITTSBURGH, Sept. 11, 2014 /PRNewswire-iReach/ -- Today the FDA announced approval of PleximmuneTM, a blood test from the Pittsburgh-based biotech company Plexision. This test predicts acute cellular rejection of transplanted livers and intestines in children. PleximmuneTM is a first-in-class test to determine a personalized rejection-risk index using cell-based technology.
27
Nov

Prognostic cell-based assay predicts acute cellular rejection in pre- and post-transplant testing of children with liver and intestine transplantation (LTx, ITx).

Below is an extract of the original abstract from the Liver Meeting help in Washington DC.© The American Association for the Study of Liver Diseases. Original abstracts could be accessed via their site here

Pages


Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2786) in /home/plexision/public_html/includes/bootstrap.inc on line 1486

Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2786) in /home/plexision/public_html/includes/bootstrap.inc on line 1490

Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2786) in /home/plexision/public_html/includes/bootstrap.inc on line 1490

Warning: Cannot modify header information - headers already sent by (output started at /home/plexision/public_html/includes/common.inc:2786) in /home/plexision/public_html/includes/bootstrap.inc on line 1490
Blog | Plexision

Error

The website encountered an unexpected error. Please try again later.